Dr. Rajeev Gupta
Dyslipidemia in Hypertension: Importance of Statins for Primary Prevention
- High blood pressure (BP) is the most important cause of global mortality and morbidity.
- Management of hypertension should move away from the “number-based” approach to “risk-based” therapy.
- Raised LDL-C is the most important CVD/CAD risk factor and contributes to “residual risk” in BP management.
- Large randomized controlled trials (RCTs) and metaanalyses have reported that the addition of statin to BP-lowering medicines significantly reduces CV risk and events (additional benefit reduction of 15-30%).
- Polypill RCTs have also reported a significant lowering of CV risk in uncomplicated hypertension.
- Hypertension guidelines should recommend the addition of statins to usual care in moderate and high uncomplicated hypertension.
Dr. Rajeev Gupta
Dr. Rajeev Gupta is a Consultant Physician in C Scheme, Jaipur. Dr. Rajeev Gupta practices at KDG Medical & Dental Centre in C Scheme, Jaipur. He completed MBBS from Sardar Patel Medical College in 1976 and MD - (General Medicine) from Postgraduate Institute of Medical Education and Research, Chandigarh in 1979.
More FAQs by Dr. Rajeev Gupta
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article